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1. Introduction 
Coronary vessels are of particular clinical interest to the general public and adult 
cardiologists because of their propensity in populations of developed countries  
to get clogged leading to chest pain (angina) and heart attacks (myocardial infarctions;  
MIs). Coronary artery disease (CAD) is the leading type of heart disease and the leading 
cause of deaths in the USA in both men and women (representing 51% of all cardiovascular 
diseases in 2006; American Heart Association Heart Disease and Stroke Statistics 2010 
Update-at-a-glance; http://www.americanheart.org/downloadable/heart/1265665152970DS-
3241%20HeartStrokeUpdate_2010.pdf; http://www.nlm.nih.gov/medlineplus/coronaryartery 
disease.html). While the developmental biology of cardiac vessels seems removed from this 
concern for the adult population, findings from this field may be beneficial and relevant for 
all age groups. Interest in the development of coronary vessels has increased due to findings 
that suggest the embryonic epicardium provides components of the coronary vessels and 
factors that positively influence the myocardium. The possibility has been raised that the 
epicardium might be sufficiently activated to repair cardiac tissue in the adult in part by 
promoting coronary vascularization. The aim of this Chapter is to call attention to questions 
regarding coronary vessels that still require answers and to introduce hypotheses that may 
lead to answers and strategies for cardiotherapy.  
2. The structure of coronary vessels and lymphatics in the four-chambered 
heart (Allen et al., 2007) 
The coronary circulation performs critical functions for the heart as in all organ systems in 
delivering oxygen and nutrients through the arteries and removing deoxygenated blood 
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and waste through the veins. The lymphatic circulation removes excess fluid within the 
tissues. In the context of the energy-intensive requirements of the continuously beating 
heart, the coronary circulation must meet particularly demanding functional requirements 
that are reflected in its architecture.  
The major vessels of the heart termed the coronary arteries have a very stereotyped 
architecture (Fig. 1A) that is conserved across individuals within a species and in large part 
across species (Tomanek et al., 2006b; Sedmera and Watanabe, 2006). With rare exceptions 
(Frommelt and Frommelt, 2004; Jureidini et al., 1998; Matherne, 2001), the mature four-
chambered heart has right and left coronary arteries connected to the aortic lumen by two 
ostia centrally placed in the right and left sinuses of Valsalva, behind the valvular cusps at 
the level of the aortic valve. The left main coronary artery (LCA) bifurcates into (1) the 
circumflex branch of the left coronary artery that wraps around the left atrioventricular 
groove and (2) the left anterior descending (LAD) coronary artery that courses over the 
interventricular septum. Other terms for the LAD are anterior interventricular branch of the 
left coronary artery or anterior descending branch. The right coronary artery (RCA) arises 
from the right sinus of Valsalva and courses right and posteriorly often with an anterior 
branch that goes to the sinus node and a posterior branch, the atrioventricular (AV) nodal 
artery. The main RCA follows the right atrioventricular groove and turns to run along the 
interventricular sulcus as the posterior descending artery (PDA). In contrast to other tissues 
that are perfused during systole (end of cardiac contraction when the ventricles are most 
contracted), the myocardial perfusion of the left ventricle occurs mainly in diastole (when 
the ventricular lumens are most dilated), while the myocardium of the right ventricle is 
perfused both during systole and diastole (Epstein et al., 1985; Fulton, 1964; Mosher et al., 
1964). 
There are rarely variations in the major coronary arteries, however there are some 
variations found in the more distal vessels that have no apparent negative consequences, for 
example coronary artery dominance. Dominance is determined by what supplies the 
posterior descending artery (PDA; posterior interventricular artery). In 69% of the 
population, the right coronary artery is dominant giving rise to the posterior descending 
coronary artery, which extends to the apex and supplies the posterior part of the ventricular 
septum, the inferior wall of the left ventricle and the atrioventricular node. In 11% of the 
population, the left coronary artery is dominant giving rise to the posterior descending 
coronary artery via the circumflex artery (CF). In 20% of the population it is co-dominant. 
The dominance has no apparent effect on function under normal circumstances, but is 
important to note when considering the extent of myocardial damage when a particular 
artery is occluded or negatively affected. The major coronary arterial system distributes 
blood to the microcirculation such as capillaries and postcapillary venules which are the 
main sites of interchange of gas and metabolite molecules between the tissue and blood.  
The major cardiac veins run along similar avenues as the major arteries. The middle cardiac 
vein runs within the epicardium from the apex to the base on the posterior surface of the 
interventricular groove and connects to the coronary sinus. This vein is generally paired 
with the PDA. Anterior cardiac veins connect to the small cardiac vein that runs posteriorly 
along the right atrioventricular groove with the right coronary artery and connects to the 
coronary sinus where the middle cardiac vein also connects. The great cardiac vein courses 
along the anterior interventricular groove from the apex to the base and wraps around the 
left atrioventricular groove posteriorly and connects to the coronary sinus. The coronary 
sinus ultimately drains into the right atrium (Gensini et al., 1965; Gilard et al., 1998). 
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Fig. 1. Normal morphology and the most frequently seen congenital coronary anomalies. 
A: Normal coronary artery morphology. B: The circumflex artery originating from the right 
coronary artery near the right sinus of Valsalva. This is the most common coronary artery 
anomaly (35% of cases). C: The left coronary artery originating from the right sinus of 
Valsalva. This anomaly carries an increased risk of sudden death. D: The right coronary 
artery originating from the left sinus of Valsalva. The frequency of this anomaly is around 
30%. E: A single coronary artery originating from either the left or right sinus of Valsalva. 
The frequency of this anomaly is between 5-20%. Note only a single left coronary is shown. 
F: The left coronary artery originating from the pulmonary artery. LA, left atrium; RA, right 
atrium; Ao, aorta; Pt, pulmonary trunk; RC, right coronary; LC, left coronary; LAD, left 
anterior descending; CF, circumflex. (Illustrations by Laura M. Bock, BFA). 
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The cardiac lymphatic system (Miller, 1982) also has its larger vessels within the epicardium 
but their anatomy is not often covered in commonly used textbooks. Surgeons concern 
themselves with the connection of the largest lymphatics such as the thoracic duct that 
drains most of the body except the right upper quadrant and usually connects at the 
junction between the left internal jugular and left subclavian veins. These are not strictly 
cardiac lymphatics as they are outside the heart. The largest distributing lymphatic vessels 
within the heart are found in the epicardium running alongside the larger blood vessels. 
These are connected to a meshwork of lymphatic capillaries that lie within the myocardium 
mainly in the ventricular walls. While the epicardial lymphatics are documented in several 
studies, the findings regarding the myocardial lymphatics of the adult heart are 
controversial and complex and will be discussed separately in a review in preparation 
(Thomas, A., Watanabe, M. et al., personal communication).  
Thus the largest cardiac vessels whether arteries, veins or lymphatics are found embedded 
within the thick epicardium of the sulcus regions as in the atrioventricular groove and the 
dorsal and ventral interventricular grooves. This pattern raises several questions. How is 
this stereotyped pattern of the major named coronaries and veins set up and maintained?  
Why do the largest coronaries course within the epicardium and do not end up more often 
within the myocardium as in the cases of myocardial bridging?  Why do the left and right 
coronary arteries normally connect only in two places at the left and right cusps of the aorta 
and not at the other posterior aortic cusp or at the cusps of the pulmonary artery?  What 
regulates the density of vessels within the epicardium and myocardium and their 
diameters? The answer to these questions may aid us on intervening in cardiac disease by 
coaxing collateral growth or enhancing vascular density when myocardial infarctions are a 
danger or prior to major cardiac surgery. While these fundamental questions have yet to be 
definitively answered, some hypotheses emerge from studies of the events during coronary 
vessel development in the embryo and fetus that will be discussed in subsequent sections. 
3. Coronary anomalies and consequences. Clinically significant anomalies 
associated with sudden death and propensity to ischemic heart disease 
The major coronary arteries generally follow a specific morphological template (Fig. 1A). 
Variations from this morphology are rare and may not have clinically significant 
consequences but are nonetheless important to know about prior to procedures in cardiac 
surgeries or when inserting leads for pacing for electrophysiological studies. However, 
specific classes of anomalies have been associated with an increased risk of sudden and 
exercise related death (Cheitlin and MacGregor, 2009; Eckart et al., 2006a; Frescura, 1999; 
Haugen and Ellingsen, 2007; Taylor et al., 1992).  
Overall, coronary artery anomalies represent a rare and small group of malformations, that 
are nonetheless important. These anomalies may be isolated or occur as a part of complex 
congenital heart diseases or associated with  hypertrophic cardiomyopathy, dilated 
cardiomyopathy and sudden cardiac death.  
The clinically significant anomalies are near the proximal attachment to the aorta and have 
been associated with exercise-related deaths. The anomaly in which the left circumflex arises 
from the right main coronary artery passing posterior to the aorta is the most common 
coronary anomaly accounting for about 35% of coronary anomaly cases (Fig.1B). There are 
usually no clinical complications, but compression by the aorta and mitral valve has been 
reported. In the latter case, implantation of a prosthetic fixation ring could be considered. 
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This implantation is a series of procedures for the replacement of the mitral valve with an 
artificial mitral valve and supporting ring (Chiam and Ruiz, 2011).  
Another anomaly in which the left coronary artery arises from the right sinus of Valsalva 
(ARCA) and passes between the aorta and the pulmonary artery is rare (3% of cases of 
coronary anomalies), but has been associated with sudden death (Fig.1C). In this case, it is 
presumed that during exercise, the abnormal position of the coronary artery running between 
the aorta and pulmonary trunk causes it to be compressed by the dilated arteries during 
exercise thus reducing blood flow to a large portion of the heart. There are 4 possible routes for 
the left main coronary artery (1) posterior to the aorta, (2) anterior to the right ventricular 
outflow tract, (3) within the ventricular septum under the right ventricular infundibulum, and 
(4) between the aorta and the right ventricular outflow tract (Fig.1C). Because this last variant 
carries an increased risk of sudden death, surgical reimplantation may be necessary.  
Taylor et al. (Taylor et al., 1992) reviewed the records of 242 patients with isolated coronary 
artery anomalies and determined that sudden death and exercise related death were most 
common when the origin of the left main coronary artery came from the right coronary 
sinus. High risk anatomy involved abnormalities of the initial coronary artery segment or 
coursing of the anomalous artery between the aorta and pulmonary artery. Frescura et al. 
(Frescura et al., 1998) analyzed the anatomic collection of 1,200 specimens of individuals 
with congenital heart disease and anomalous origin of coronary arteries was observed in 27 
of these individuals (2.2%). This study concluded that more than half of the postmortem 
cases with an anomalous origin of the coronary arteries died suddenly. Eckart et al., (Eckart 
et al., 2006b) reviewed the autopsy reports of sudden cardiac deaths involving U.S. military 
recruits during basic training from 1977 through 2001. This study found that all sudden 
cardiac deaths resulting from anomalous coronary origin involved a left main coronary 
artery originating from the right coronary sinus with a course between the aorta and the 
right ventricular outflow tract and an otherwise normal distribution of the other major 
epicardial coronary arteries. 
Anomalous origin of right coronary arterial branches from the left sinus of Valsalva occurs 
in approximately 30% of all major coronary arterial anomalies (Fig.1D). In this condition, the 
right coronary artery runs between the aorta and the right ventricular outflow tract. Since it 
carries increased risk for sudden death as does certain cases of ARCA, surgical 
reimplantation is recommended. 
The anomalous left coronary from the pulmonary artery (ALCAPA; Bland-White-Garland 
syndrome; Fig. 1F) results in left ventricular insufficiency or infarction and infants with this 
condition have a high mortality rate; 65-90% die before age 1 from congestive heart failure 
(Park, 1988; Pena et al., 2009). This anomaly is usually isolated but can be associated with 
other congenital heart anomalies such as Tetralogy of Fallot or coarctation of the aorta. It 
usually presents at birth or shortly after with an increase in myocardial ischemia followed 
by exhaustion of the coronary vascular reserve. Due to the transition in the neonatal 
circulation, the pressure in the pulmonary artery remains high. As the pulmonary artery 
pressure drops, there is more flow from the aorta into the pulmonary artery through the 
coronary circulation. This results in decreased perfusion of the myocardium and leads to 
myocardial ischemia. Initially this condition may be transient but with increased exertion, it 
progresses to infarction of the antero-lateral left ventricle or free wall with dysfunction. 
Mitral regurgitation can develop secondary to left ventricular delectation and infarction 
and/or dysfunction of the anterolateral papillary muscle. Diffuse endocardial fibroelastosis 
of the left ventricle and thickening of the anterior mitral valve leaflet can also occur.  
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Infants may present with heart failure and the signs of myocardial infarction in the form of 
irritability with feeding or activity. Older children may be asymptomatic or may have 
dyspnea, syncope, or angina. Sudden cardiac death after exertion has been known to occur 
(George and Knowlan, 1959). 
The electrocardiogram shows abnormal Q waves in the leads I, aVL and pre-cordial leads 
V4 to V6.  Noninvasive imaging like echocardiography will confirm the diagnosis in most of 
the cases. If uncertain, angiography or computed tomography (CT ) scan with higher 
resolutions can complement and confirm the diagnosis and also provide insight into the 
extent of collaterals and help in sorting out which coronary artery is dominant.  
About 87% of the patients present in infancy (Neufeld, 1983) and of these 65% to 85% die 
before one year of age due to congestive heart failure and infarction (Wesselhoeft et al., 
1968). It is noted that if the children improve spontaneously (Liebman et al., 1963), it might 
be from formation of extensive collaterals or there could be ostial stenosis at the entry of the 
anomalous coronary into the pulmonary artery, thus conferring slight protection. However, 
they are still at high risk of sudden cardiac death with exercise (Fontana, 1962). 
The treatment of such a condition is surgical implantation of the left coronary artery into the 
aorta (Grace et al., 1977; Huddleston et al., 2001; Jin et al., 1994; Schwartz et al., 1997). An 
alternative is  the Takeauchi procedure, in which an aorto-pulmonary  window is created with 
a tunnel that leads the blood from the aorta to the coronary artery (Takeuchi et al., 1979). 
ALCAPA has been separated into the infant type and the adult type (Pena et al., 2009). The 
infant type is as described earlier in this paragraph. The rare adult type is hypothesized to 
be the cause of sudden cardiac death that occurs in 80-90% of these individuals. Survival of 
the adult with ALCAPA is possible because of the development of collaterals between the 
left and right coronary arteries. In these cases there is likely a pulmonary-coronary steal 
with a left to right shunt. These account for 15% of ALCAPA  patients where the myocardial 
blood flow can sustain myocardial function at rest or even during exercise allowing these 
individuals to reach adulthood (Neufeld, 1983). 
Even with these collaterals, there is not enough circulation to the left ventricle resulting in 
ischemia. Surgical repair is usually required and is carried out for the infant by direct 
reimplantation of the origin of the left coronary artery into the aorta with a “button” (small 
segment) of pulmonary artery. 
Single coronary artery (Fig. 1E): At a frequency of 5-20% of coronary anomalies, a single 
coronary artery arises from the aorta and then branches to give rise to the right and left 
coronaries (Ogden, 1970; Shirani and Roberts, 1993). As many as 40% of single coronary artery 
cases are associated with other congenital cardiac defects such as Tetralogy of Fallot. This 
anomaly carries a mildly increased risk of sudden death. The branches can pass between the 
two great arteries, resulting in compression. Of course with only one trunk there is increased 
vulnerability. For example, atheroma formation (swelling and accumulation of material) at the 
single trunk can be critical. Surgical repair is considered on a patient to patient basis. 
Coronary artery fistulae [reviewed in (Luo et al., 2006; Schamroth, 2009) and 
(http://emedicine.medscape.com/article/895749-overview)]: Coronary artery fistulae (CAF) 
are major abnormal connections between a coronary artery and a cardiac chamber (coronary-
cameral fistula) or inappropriate vessels and vascular structures (coronary arteriovenous 
fistula for coronary arterial-venous fistulae; CAVFs) and occur in 50% of coronary vasculature 
anomalies. For the most part, fistulas are small, have no untoward consequences to 
hemodynamics, and require no clinical intervention. These are only discovered when 
echocaradiography or coronary arteriography are performed for other reasons. Larger fistulae 
may continue to enlarge and eventually cause the “coronary artery steal phenomenon” in 
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which blood flow to the myocardium is compromised and may cause ischemia during 
increased activity. These fistula require surgical or percutaneous intervention for their closure. 
It is proposed that these inappropriate connections are remnants of the primitive coronary 
network that have failed to remodel and regress appropriately. 
The range of symptoms associated with coronary artery anomalies can vary based on the 
specific type of lesion. However, the general concept is based on an imbalance between supply 
and demand of myocardial perfusion and also due to the steal phenomenon associated with 
left to right shunting. There are three coronary anomalies associated with myocardial 
ischemia, infarction, and/or lethal arrhythmias which could then lead to fibrillation or 
electromechanical dissociation. These are ALCAPA, coronary artery arising from the wrong 
sinus and coursing between the two great arteries, and large coronary artery fistula.  
A history of unexplained syncope (loss of consciousness or fainting) or syncope associated 
with exercise should raise a diagnostic possibility of an anomalous coronary artery. Initial 
tests would include an electrocardiogram to rule out arrhythmia, left ventricular 
hypertrophy or prior evidence of ischemia. An echocardiogram is very helpful in identifying 
the coronary artery origin and its proximal course should be studied with utmost care. 
Hypertrophic cardiomyopathy should be ruled out using this method. If the 
echocardiogram raises the suspicion and is unable to provide enough information, a 
transesophageal echocardiogram, magnetic resonance imaging and/ or CT scan may be 
more sensitive and should be considered (Schmitt et al., 2005). 
While the association between sudden death and coronary anomalies has been made for 
certain such anomalies, no treatment has been established for individuals identified with 
these anomalies but suffering no symptoms. 
Classification of coronary artery anomalies: Coronary artery anomalies can be classified as  
abnormal origin of the coronary arteries from the wrong aortic sinus, anomalous origin of 
the left or the right coronary artery from the pulmonary artery, absence of a coronary artery, 
and congenital coronary artery fistulas (See Table 1). 
 
Significant congenital anomalies of the coronary arteries 
I. Without congenital heart disease 
 A. Coronary arteries arising from the wrong sinus
  i. without intramural course 
  ii. with intramural course (within the media of the great vessels) 
 B. Anomalous origin of the coronary arteries from the pulmonary arteries 
  i. ALCAPA*
  ii. ARCAPA.*
 C. Single coronary artery or absence of a coronary artery
 D. Coronary artery fistulas
 E. Myocardial bridging
II. Coronary artery anomalies associated with congenital heart disease 
 A. Transposition of the great arteries 
 B. Tetralogy of Fallot
 C. Pulmonary atresia with intact ventricular septum
 D. Aortic atresia with mitral atresia/stenosis
*ALCAPA: anomalous origin of the left coronary artery from the pulmonary artery;  
*ARCAPA: anomalous origin of the right coronary artery from the pulmonary artery. 
Table 1. 
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Myocardial bridges are another class of coronary anomalies where an artery that normally 
confines its path within the epicardium dives and travels several millimeters within the 
myocardium before the terminal branches [Reviewed in (Boktor et al., 2009; Hakeem et al., 
2010; Sunnassee et al., 2011; Vales et al., 2010)]. Myocardial bridging has been described as 
early as 1737 (Rayman, 1737) and have been described since with a wide range of 
frequencies reported. In one study of 200 adult human hearts collected from autopsies, 
myocardial bridges were found in 34.5% with a mean length of 31 mm and a mean depth of 
12mm (Loukas et al., 2006). The most common site of myocardial bridging was over 
portions of the left anterior descending coronary artery (LAD). Myocardial bridging usually 
does not carry a significant increase in risk of sudden death, however ischemia has been 
reported, in particular when associated with hypertrophic cardiomyopathy. Angiography 
has identified compression of arteries at the site of myocardial bridging during systolic 
contraction (Laifer and Weiner, 1991). Surgical repair is considered in select cases to remove 
the myocardial bridge when there are symptoms such as angina or myocardial infarction. 
Many patients with myocardial bridges are asymptomatic, but these bridges are 
hypothesized to lead to a tendency to develop myocardial infarction (MI), ischemia, and 
other cardiac problems. Long bridges are associated with negative cardiac symptoms 
(Bourassa et al., 2003). Paradoxically myocardial bridges have been proposed to lead to a 
decrease or an increase of atherosclerosis. Myocardial bridges correlate with left coronary 
artery dominance and are thought to be the result of developmental events. Why 
myocardial bridges and coronary artery dominance would be related is a mystery.  
 
 
 
Fig. 2. EF5 at hypoxic regions where major coronary vessels will differentiate. A: EF5 
staining in frontal sections of st 30 chicken hearts B: Higher magnification of a region similar 
to that in the box in A. C: Higher magnification of a region indicated by the box in A. 
Arrows indicate lumens of small vessels. Scale bar in A = 500 μm and 200 μm in B & C. 
(Wikenheiser et al., 2006). 
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Summary: The coronary artery anomalies discussed above are presumed to arise in the 
embryonic or fetal stages of cardiovascular development from as yet unknown causes. 
Recent investigations described in Section V, suggest that some coronary anomalies may 
involve disturbance of a “hypoxic template”. Anomalies in the proximal arteries 
resembling those observed in clinical specimens have been reproduced in avian embryos 
subjected to conditions that would alter this hypoxic template (Fig 2). ;(Wikenheiser et al., 
2009). 
Much less attention has been paid to anomalies of the cardiac veins and lymphatics. In one 
case study, the importance of venography prior to inserting a pacing lead into the coronary 
sinus was underscored because the contrast agent indicated that the lead may have entered 
an anomaly of the middle cardiac vein (Yuniadi et al., 2004). 
4. Development of coronary vessels 
The proepicardial serosa and the embryonic epicardium are known to be sources for the 
components of the cardiac vessels in the embryo. Recent evidence suggests that the adult 
epicardium can also be activated to contribute to the vasculature and even the 
cardiomyocyte population. A number of apparently conflicting interpretations of the data 
and caveats have been raised that are worth discussing regarding this important cardiac 
tissue. 
The proepicardium and the embryonic epicardium have been the focus of and continue 
to be the focus of much study [reviewed in (Gittenberger-de Groot et al., 2010; Olivey et 
al., 2004; Ratajska et al., 2008; Tomanek, 2005; Wessels and Perez-Pomares, 2004)] because 
it is the source of many cell types critical for the heart including components of the 
vasculature. The embryonic epicardium arises from the serosal covering of the body wall 
between the sinus venosus and the future liver. The mesothelial cells at this caudal border 
of the pericardial cavity form villi and become a small mass appearing as a wrinkled 
“cauliflower-shaped” structure that is called the proepicardium (PE), proepicardial 
serosa, or proepicardial organ (PEO) (Manner, 1993). This structure grows up against the 
atrioventricular groove and migrates to the heart apparently assisted by extracellular 
matrix fibers that bridge the gap between the myocardium and the proepicardium 
(Nahirney et al., 2003; Olivey et al., 2004). This structure extends many tissue processes 
and covers the surface of the naked myocardium of the looped heart in avian species 
(Hiruma and Hirakow, 1989;  Ho and Shimada, 1978; Viragh and Challice, 1981). Bone 
Morphogenetic Protein (BMP) has been identified as a factor that may be involved in 
controlling the timing and direction of proepicardial protrusion towards the heart (Ishii et 
al., 2010). The transcription factor GATA4 has been found to be strongly expressed in the 
proepicardium and is required for the formation of the epicardium (Watt et al., 2004). 
When the GATA cofactor FOG-2 is absent in mice, the coronary vasculature does not 
develop (Tevosian et al., 2000; Tomanek, 2005). The molecular and cellular signals that 
initiate the growth and coverage of the cardiomyocytes of the embryonic heart are not 
known. It is likely that proepicardial growth and epicardium coverage would be 
coordinated closely with the level of hypoxia in cardiac tissues and the contractile 
function of the heart.  
The transition from proepicardium to epicardium is thought to differ between species 
(Nesbitt et al., 2006). While avians and rats undergo the process as described above, mice 
and zebrafish may do it a different way. In the mouse, the proepicardial processes appeared 
www.intechopen.com
 Vasculogenesis and Angiogenesis – From Embryonic Development to Regenerative Medicine 24
to be released as vesicles from the proepicardial serosa that float in the pericardial space and 
attach to the surface of the myocardium (Viragh and Challice, 1981). Whatever method is 
used for a particular species, the signal that induces the growth and attachment of the 
proepicardial processes or vesicles is incompletely understood but likely involves signals 
from the thickening myocardium and perhaps the endocardium.  
Immediately after proepicardial processes or vesicles attach to the surface of the 
myocardium, an extracellular matrix accumulates between the single layer of mesothelial 
cells and the myocardium. The epicardial coverage occurs in a stereotyped pattern in the 
avian heart with the dorsal surface of the atrioventricular junction covered first and 
radiating out from there, wrapping around the atrioventicular groove, the ventricles and 
atria and finally the distal portion of the outflow tract (Hiruma and Hirakow, 1989; Ho and 
Shimada, 1978). This distal portion of the outflow tract has been shown to be covered by 
epicardial cells from another more cephalic source even when the proepicardial serosa is 
ablated or impeded (Gittenberger-de Groot et al., 2000). These cells have a different 
morphology (more cuboidal than squamous), different gene expression, and may also have 
different capabilities and properties (Perez-Pomares et al., 2003).  
The embryonic epicardium consists of a single layer of mesothelial cells, underlying 
connective tissue, and mesenchymal cells within the connective tissue. These mesenchymal 
cells arise from epithelial-mesenchymal transition (EMT) of the mesothelium but may also 
come from the sinus venosus or liver primordia (Perez-Pomares et al., 1997; 1998; Dettman 
et al., 1998). The cells that undergo EMT are termed epicardial derived cells (EPDCs) and 
have been tracked into the subepicardium, myocardium and even into the endocardium at 
sites where valves form (Gittenberger de Groot et al., 1998). Some EPDCs differentiate into 
the components of the coronary vasculature.  
Epicardial EMT is stimulated by vascular endothelial growth factor (VEGF), fibroblast 
growth factors (FGF-1, FGF-2 and FGF-7) and epidermal growth factor (EGF), but is 
inhibited by transforming growth factor (TGFb-1-3) (Morabito et al., 2001). The proposed 
inhibitory role of TGF-ǃ in epicardial EMT is in contrast to its positive role in endocardial 
EMT and is still seen as controversial (Compton et al., 2006; Olivey et al., 2006). When the 
myocardium in the embryonic mouse produces an excess of angiopoietin-1 (Ang1), the 
epicardium fails to develop and that results in an absence of coronary vessels and death 
(Ward et al., 2004).  
The epicardium as a source for cardiac cell types. Lineage studies were conducted using 
retroviral labeling by injection of engineered virus into the proepicardium (Mikawa and 
Fischman, 1992). As retroviruses were used for the transfection of reporter genes,  the genes 
integrate into the genome and clonal analysis is possible over many stages of development. 
In the case of these studies, the reporter gene was the bacterial lac-z gene expressing the 
enzyme beta-galactosidase that can be detected using a dye substrate that turns into a blue 
precipitate within the cell expressing the reporter gene. The analysis of individual discrete 
clones of blue cells revealed that there were clones with only endothelial cells or clones with 
smooth muscle cells and fibroblasts, but no clones were found that included the 
combination of endothelial cells and smooth muscle cells or endothelial cells and fibroblasts. 
The findings suggested that there are two populations of precursor cells in the 
proepicardium, one population that became endothelial cells and a separate population that 
became smooth muscle cells and fibroblasts. In this study, the virally marked proepicardial 
cells could have been either the mesothelial cells or the mesenchymal cells of the 
proepicardium.  
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Many studies using different approaches confirm that the epicardium can give rise to 
vascular smooth muscle cells and fibroblasts. However, some lineage tracing approaches 
do not clearly support that the epicardium serves as a source of endothelial cells. 
Furthermore, the potential for the epicardium to provide precursors of cardiomyocytes is 
an exciting idea for cardiac therapy, but has been even more controversial and will be 
discussed below.  
4.1 Where do endothelial cells in the heart come from? 
The origin of endothelial cells is still somewhat controversial with several theories being 
discussed. The theories can be separated into three. 
1. The epicardial mesothelial layer undergoes epithelial-mesenchymal transition (EMT) 
and  gives rise to EPDCs (epicardial derived cells ) that travel into the epicardium or 
myocardium and  become endothelial cells that form vascular tubes and vessels by 
vasculogenesis. 
2. Endothelial precursors travel within the connective tissue of the epicardium as 
mesenchymal cells, but do not derive from the epicardial mesothelium. These 
precursors use the connective tissue of the epicardium as a conduit as do neural crest 
cells and may originate from outside the heart in the liver primordia. 
3. Precursors come from the sinus venosus and veins that transdifferentiate into 
endothelial cells of the arteries and use the epicardium as a conduit as in (2) (Red-Horse 
et al., 2010). 
4. Endocardial cells differentiate into endothelial cells of the myocardium. 
Our findings suggest that lymphatic endothelial precursor cells may travel from outside the 
heart using the epicardial lining of the outflow tract to travel into the heart (Karunamuni et 
al., 2010) supporting scheme (2). We also have evidence that lymphatic endothelial cells may 
also come from precursors within the epicardium. 
The Cre-Lox method of lineage tracing has been used widely to trace cell fate and to find 
evidence for coronary vessel precursors so it is worth discussing the caveats of using this 
technique. Findings using this method have suggested that cardiomyocytes and few if any 
endothelial cells arise from the embryonic epicardium. Concerns have been raised 
regarding the lineage tracing of epicardial cells by this method. The Cre-mice available 
include, Wt1-Cre, TBX18-Cre and Gata5-Cre, that do appear to allow epicardial specific 
expression when analyzing limited areas of the heart at certain stages (Cai et al., 2008; 
Sridurongrit et al., 2008; Zhou et al., 2008). However, these may not be as specific as 
desired. For example, Wt1-Cre is expressed by cardiac progenitors in the secondary heart 
field so it may label the lineage prior to their split into myocardial and epicardial lineages. 
TBX18 is known to be expressed in a subset of cardiomyocytes that are not of epicardial 
origin (Christoffels 2009). Cre expression can be irreversibly turned on even if the 
expression of the gene is expressed transiently and in low levels. This expression would 
be difficult to detect and characterize histologically by immunostaining or in situ 
hybridization for TBX18 itself.  
To address this problem in studies of the role of the epicardium in the adult mouse heart, 
the Wt1-CreERT2 tamoxifen-inducible reporter constructs have been used (Smart et al., 
2011; Zhou et al., 2011). This strategy allowed the investigators to label with a fluorescent 
reporter (YFP) only those cells expressing Wt1 at the time of tamoxifen injection. Wt1 and 
YFP expression appeared to be epicardial specific in the adult. However, the same criticism 
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could be invoked for this strategy as for the strategy used to mark the epicardium in the 
embryo. Thus, transplantation of lineage labeled and explanted epicardial cells was used to 
support the findings using the Cre-line (Zhou et al., 2011). 
Given the uncertainties of the Cre-Lox method of lineage-tracing, several groups have found 
that the epicardial/mesothelial Cre lineage tracing (Wt1-Cre, TBX18-Cre) rarely if ever 
provided endothelial cells to the heart or other organs (Cai et al., 2008; Que et al., 2008; 
Wilm, 2005; Zhou et al., 2008). Other groups including ours found that endothelial cells are 
indeed part of the Wt1-Cre lineage (personal communication). The staining protocol, 
background of the mice, and the Cre-construct might be the variables that result in these 
differences in findings between laboratories. 
In summary, multiple avenues for endothelial cells precursors to contribute to the heart 
have been proposed and at this point, all may be correct. 
Coronary vascular development. Several reviews summarize what is known about 
coronary vascular development (Lie-Venema et al., 2007; Olivey et al., 2004; Olivey and 
Svensson, 2010; Reese et al., 2002; Tomanek, 2005; Wada, 2003; Wessels and Perez-
Pomares, 2004). Precursors of the coronary vasculature are contributed by the embryonic 
epicardium that arises from the pro-epicardial serosa at a stage when chamber 
differentiation has begun (Hiruma and Hirakow, 1989; Ho and Shimada, 1978; Viragh and 
Challice, 1981). The function of the primitive coronary vascular system prior to exhibiting 
the mature pattern of two arterial connections with the aortic lumen is not known. Are 
they already moving blood and fluid within the heart? What are the hematopoietic 
properties of epicardial cells? 
Quail endothelial precursors and hemangioblasts are labeled by an antibody Qh-1 (Eralp et 
al., 2005; Kattan et al., 2004) and appear as individual cells along the back (dorsal surface) of 
the atrioventricular junction (AVJ), eventually covering the entire heart (Fig. 5). These cells 
accumulate around the proximal OFT and right ventricular base to form a peritruncal ring 
of anastomosing capillary-like vessels that surrounds the proximal OFT myocardium and 
cranial portion of the ventricles in the epicardium (Fig.6). Some vessel precursors enter the 
myocardium and make multiple connections to the aortic lumen. Subsequent remodeling 
results in maturation and maintenance of the roots of the right and left coronary arteries 
connecting to the mature branching vasculature (Tomanek et al., 2006a; Tomanek et al., 
2006b; Waldo et al., 1990). Early assembly of coronary vessels occurs by vasculogenesis, the 
formation of blind-ended tubes that connect with each other to form continuous vessels 
(Kattan et al., 2004; Mikawa and Fischman, 1992). Once these tubes are connected to each 
other and to the aortic lumen, angiogenesis, the growth of vessels from preexisting vessels, 
becomes a prominent mechanism for coronary growth. The signals that promote the 
formation of the nascent tubes and their eventual connection to each other and to the aortic 
lumen are incompletely understood. Another equally important issue is the remodeling that 
eliminates nascent vessels during the transformation of the primitive vascular network into 
a mature branching vasculature. 
To complicate this picture of coronary vessel development, Qh-1 labels not just blood vessel 
precursors but distinctly labels lymphatic precursors (Parsons-Wingerter et al., 2006) in the 
chorioallantoic membrane (extraembryonic tissue) and we have recently found that the 
same is true in the developing epicardium (Karunamuni et al., 2010). Therefore, some of the 
structures labeled with Qh-1 and identified as nascent blood vessels may be nascent 
lymphatic vessels. 
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Fig. 3. Hypoxia-induced defects in coronary vessels. Transverse sections of stage  
35 (ED 9) chicken embryo hearts stained with anti-a-smooth muscle actin-Cy3(A,B).  
A,B,C were incubated in 20.8% O2 (normoxic) conditions. D-H were incubated in 15% O2 
(mildly hypoxic) for 4.5 days. 9 out of 10 embryos had defects that ranged from offset 
RC’s near the posterior cusp (D,H), double RC’s (F, G), & swollen RCs (E,F). LC’s were 
tortuous and extended into abnormal positions (D). Ao = aorta, Pt =pulmonary trunk,  
RC = right coronary, LC = left coronary. [From (Wikenheiser et al., 2009)] 
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Fig. 4. Abnormal course of the posterior descending branch of the coronary artery after 
exposure to hypoxic conditions. The coronary vessels were filled by back-injection with  
blue ink into the aorta. The posterior vessel  normally runs straight down the 
interventricular septum towards the apex (A; white arrows). This hypoxic embryo heart (B) 
had a vessel that diverged from this pathway along the sulcus before reaching the apex. 
These embryos were exposed to 15% O2 at stage 24-32, when coronary vessels are 
differentiating and remodeling, and harvested at stage 38. 
 
 
 
 
 
Fig. 5. Qh-1+ staining of vascular precursors cells in the epicardium of the quail heart  
(stage 24). At a stage prior to the formation of the four cardiac chambers, labeling using the 
antibody marker Qh-1 for endothelial cells and precursors revealed an evenly spaced set of 
cells covering the ventricular (Vent) and atrial (Atrium) surfaces and parts of the outflow 
tract (OFT). Will of these cells become endothelial cells and into which endothelial lineage 
will they be incorporated, arterial, venous or lymphatic?  Why are they so evenly scattered 
at this stage and why aren’t many covering the OFT. Qh-1 labels lymphatic endothelial cells 
as well as blood vessel endothelial cells and hemangioblasts. 
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Fig. 6. Confocal microscopy of intact embryonic day E13.5 mouse heart double-labeled with 
an antibody to an endothelial marker PECAM (green) at the level of the outflow tract. The 
periarterial anatomoses, the primitive coronary vasculature surrounds the outflow tract. 
Lysotracker Red staining indicates that most of the apoptotic cells are within the 
myocardium not in the vasculature. The aorta (ao) and pulmonary artery (pa) are indicated 
at a low magnification (A, 100x) and higher magnifications are in (B, 200x) and (C, 400x) 
(Barbosky et al., 2006). 
5. Origin of the lymphatics 
Much less is known about the development of the lymphatics compared to the blood vessels 
within the heart. A number of reviews have been recently published regarding 
lymphangiogenesis (Albrecht and Christofori, 2011; Schulte-Merker, 2011; Witte et al., 2011). 
Transgenic mice have been created and markers for lymphatics have been identified that have 
made the study of lymphatic development much more accessible. The markers include 
antibodies to Prox-1, Lyve-1, Podoplanin, and VEGFR3. Unfortunately, these have limited use 
when used individually because, they are not exclusive to lymphatic endothelial cells especially 
in the embryo. They are useful in identifying bona fide lymphatic endothelial cells within the 
epicardium when used in combination (Karunamuni et al., 2010). It is quite clear that there are 
lymphatics in the epicardium of the adult heart but it is not known where they come from and 
exactly how they are distributed within the myocardium and endocardium. In view of their 
potential importance in cardiac homeostasis and disease, much more work is warranted.  
6. Regulation of cardiac blood vessel development 
Coronary vessels appear at particular stages of development and particular places within 
the heart. They can also grow and increase in density within the adult heart. The regulation 
of coronary vasculature is critical for homeostasis and as a response to stress. An 
understanding of what regulates these processes would be valuable in cardiotherapy. We 
expect that cardiac vessels are subject to some of the same regulatory strategies as other 
vessels in other parts of the body. However, the specific anatomy and demands of the heart 
suggest that there are likely to be cardiac-specific regulatory mechanisms to investigate. 
The emergence of coronary vessels has been documented in quail using the antibody marker 
Qh1 that detects quail hemangioblasts/angioblasts and endothelial cells (Eralp, 2005; Kattan 
et al., 2004) and in mouse using PECAM and VEGFR2/Flk1 that detect endothelial cells 
[e.g.,(Tevosian et al., 2000)]. These early steps also appear to be choreographed such that 
precursors and endothelial cells assemble within the heart in a reproducible pattern that is 
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similar across species. The resulting mature avian coronary architecture is similar to that 
found in mammals (Sedmera and Watanabe, 2006; Tomanek et al., 2006a). The mechanisms 
by which these patterns are established have been speculated to be controlled by (1) the 
sequence of differentiation of cardiac regions, (2) mechanical factors (shear stress, cyclic 
stretch and strain), and (3) differential hypoxia. 
The location of the largest arteries in the epicardium at the sulcus regions. Why do the 
largest coronary arteries lie within the epicardium and at the sulcus regions? This can be 
separated into two questions, why are the sulcus regions preferred and why at the level of 
the epicardium rather than in the myocardium? We hypothesize that the answer may lie in 
part in the differential hypoxia at these sites during the earliest stages of coronary vessel 
development.  
Differential Hypoxia. The precursors of endothelial cells are subjected to many 
environmental influences. An obvious one is hypoxia. The lack of oxygen within cardiac 
tissues is likely the result of increased proliferation that results in tissues that are too thick 
for simple tissue diffusion to adequately provide oxygen to the cells. Increased activity of 
the constantly beating and maturing heart also depletes oxygen from myocardial tissues 
thus increasing activity would likely increase hypoxia.  
We and others (e.g. (Nanka et al., 2008; Naňka et al., 2006; Sugishita et al., 2004c; Tomanek et 
al., 2003; Wikenheiser et al., 2006)) discovered by the use of hypoxia indicators that there is a 
pattern of differential hypoxia within the embryonic heart that may explain in part why 
vessels form or are more concentrated at particular places. 
The spatiotemporal pattern of outflow tract (OFT) myocardial hypoxia as measured by the 
hypoxia indicator EF5 correlates with HIF-1a nuclear localization, cardiomyocyte apoptosis, 
and morphogenesis of the OFT in both avian and mouse embryos (Sugishita et al., 2004A, B, 
C; Barbosky et al., 2006; Wikenheiser et al., 2006). Incubation of embryos under hyperoxic 
conditions reduced tissue hypoxia, HIF-1a nuclear localization and cell death in the OFT 
myocardium and resulted in abnormal conotruncal morphologies. The expression of 
hypoxia regulated genes such as VEGFA and VEGFR2 was also affected by hypoxia and 
hyperoxia in the OFT myocardium. We concluded that relative hypoxia of the chicken 
embryo OFT at that particular stage was critical to normal morphogenesis. The hypoxia 
peak also correlated with when coronary vessel precursors accumulated around the 
proximal OFT in both chicken and mouse (Fig. 6) and when endothelial precursors invade 
the OFT myocardium (Barbosky et al., 2006; Rothenberg et al., 2002; Wessels and Perez-
Pomares, 2004). These findings supported a spatiotemporal correlation between 
microenivornmental tissue hypoxia, HIF-1a nuclear localization, accumulation of 
endothelial precursors, and myocardial invasion of endothelial precursors and vessels. 
In addition to the OFT, the hypoxia indicator EF5 bound to other cardiac regions that 
correspond to sites of coronary vessel formation. Using EF5, we determined that the chicken 
OFT myocardium was one of the most hypoxic cardiac tissues with a peak of EF5 staining 
intensity at the end of ventricular septation (Sugishita et al., 2004a; Sugishita et al., 2004c). Our 
subsequent studies (Wikenheiser et al., 2006) revealed additional intensely EF5-positive 
cardiac regions at intriguing sites that included myocardial regions of the atrial wall, the 
atrioventricular junction (AVJ), and the interventricular septum (IVS) (Fig 2). These regions 
were also positive for nuclear-localized HIF-1a suggesting that HIF-1-induced transcriptional 
regulation may be active at these sites. Many of the intensely EF5+ myocardial regions 
corresponded to sites where the major vessels of the coronary vasculature will eventually 
develop. These findings led us to the hypothesis that myocardial hypoxia at specific sites may 
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induce a level of HIF-1a mediated transcriptional activation that regulates gene expression 
critical to differentiation and organization of the coronary vasculature. The differential hypoxic 
microenvironments of the heart would provide a template for coronary vessel patterning. 
Hypoxia Inducible Factors. An important and well-studied set of hypoxia sensitive 
transcription factors are the Hypoxia Inducible Factors (HIFs) of which HIF1a has received 
the most attention. Many cellular responses to hypoxic stress are regulated by the 
transcription factor HIF-1 (Semenza, 2001) a heterodimeric transcription factor composed of 
the constitutively expressed HIF-1b (ARNT) and the oxygen-sensitive HIF-1a. Under 
normoxic conditions, HIF-1a is degraded by ubiquitination. Under hypoxic conditions, HIF-
1a escapes degradation, enters the nucleus, becomes a part of the heterdimer HIF-1, and 
binds to the CBP/p300 co-transactivator to form an active transcription complex that binds 
to hypoxia responsive elements (HREs) in promoter regions of many genes. In addition to 
this “canonical” function of HIF1a, this factor may participate in other pathways. For 
example HIF1a is known to bind to Notch and promote Notch signaling (Gustafsson et al., 
2005) that is important in regulating differentiation of various cell types.  
HIFs are critical for early development. The HIF-1a knockout mice die at E10.5 with 
abnormal morphogenesis of cardiac and other structures (Iyer et al., 1998; Ryan et al., 1998). 
The functional deletion of both HIF-1 and HIF-2 by expressing a dominant negative HIF2a 
led to embryonic lethality at E11.5. The conditional “knockout” of HIF-1a early in 
ventricular cardiomyocytes (Krishnan et al., 2008) and HIF-1 and HIF-2 by expression of a 
dominant negative HIF mutant in endothelial cells also resulted in early death [death by 
E11.5; (Licht, 2006)]. As coronary vessel development occurs at E10.5-13.5, the early death of 
these mice precluded determining the role of HIFs in coronary development by the use of 
these mice. A different strategy was required. 
The HIF-1a gene was conditionally knocked out in cardiomyocytes of the left ventricle using 
the Cre-Lox technique with Cre expression driven by the MLC2v promoter (Huang et al., 
2004). These mice survived with expected Mendelian frequencies, but with abnormal 
cardiomyocyte functions and a 15% reduction in vascularity of the left ventricle. These 
relatively mild effects suggested that HIF-1a is not required in cardiomyocytes for coronary 
vascular development, but may regulate its extent. However, compensation by HIF-2 (see 
below) or an alternate pathway is also possible. Another explanation is that the MLC2v 
promoter drives expression primarily in the left ventricle and at a late stage that may not 
knock out HIF-1a gene expression early and thoroughly enough to interfere with the 
myocardial paracrine signals for coronary development. These signals may have already 
been initiated prior to the knockout. Also the promoter may not have disabled the gene in 
the OFT myocardium or other sulcus regions where signals for early coronary development 
are likely to be critical. Their finding that smaller, recently developed vessels were more 
affected than larger vessels supports this idea. Another possibility is that VEGF and other 
important factors come from another source, the epicardium. Thus, this conditional 
knockout mouse study supported a role for myocardial HIF-1a on some aspects of coronary 
vessel organization but it is probably not the only tissue important in this function. 
The role of HIFs in the endothelium has been less easily established by conditional knockout 
studies. Specific deletion of HIF-1a in endothelial cells affected adult tumor angiogenesis but 
had no detectable effect on embryonic vascular development (Tang et al., 2004). The specific 
deletion of HIF-2a in endothelial cells has resulted in variable results ranging from no effect 
on vasculature to yolk sac vascular defects  (Compernolle et al., 2002; Duan et al., 2005; 
Peng, 2000; Scortegagna et al., 2003a; Scortegagna et al., 2003b; Tian et al., 1998). It takes the 
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functional deletion of both HIF-1 and HIF-2 by expressing a dominant negative HIF-2a to 
see an effect. This deletion as mentioned above caused a embryonic lethality at E11.5. These 
results support that HIFs can compensate for each other during development and may play 
a role in other cell types in addition to cardiomyocytes.  
A distinguishing feature of the sulcus regions of the heart where the coronary vessels first 
begin to develop and where the largest coronary arteries end up is a high level of hypoxia 
and nuclear-localized HIF-1a as well as a high level of expression of HIF downstream genes 
in both the myocardium and epicardium (Fig. 7). Therefore microenvironmental hypoxia 
may promote steps in early coronary vessel development in a region-specific pattern by 
enhancing HIF function in the epicardium as well as the myocardium.  
 
 
Fig. 7. HIF1a expressed in the epicardium. At the sulcus region of the ventricular apex were 
epicardial mesothelial cells with nuclear localized HIF1a staining (A, green). The 
myocardium is delineated using cardiomyocyte markers anti-MF20 and anti-titin (B, red). 
All nuclei are labeled with DAPI (C, blue). A composite overlay of all three colors  (D) 
indicates an example of where HIF1a is expressed in the nuclei of an epicardial mesothelial 
cell. The same cell is delineated with a white arrow in A,C,and D. 
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Molecular factors in early steps of coronary vessel development. Factors that may be 
important for epicardial EMT and differentiation of these cells have been identified. Explant 
studies point to FGF (fibroblast growth factor) 2 and 7, VEGF(vascular endothelial growth 
factor), and EGF (epidermal growth factor) as inducers of EMT with TGFb’s (transforming 
growth factor betas) acting surprisingly as inhibitors of EMT (Morabito et al., 2001). TGFb’s 
act as enhancers of EMT in endocardial cushions. Thus the set of factors that control 
epicardial EMT resemble the set that control endocardial EMT but differ in their outcomes. 
These factors are expressed, as detected by immunohistology, within the embryonic 
epicardium and/or the myocardium. Though some factors involved in EMT and subsequent 
steps in epicardial cell differentiation have been identified, the mechanism that drives their 
expression in particular patterns, sites and stages is not fully understood.  
Some of the same growth factors also influence the formation of tubes by endothelial 
precursors. These include VEGF family members and FGFs (Chen et al., 1994; Tomanek, 
2006; Tomanek et al., 2008; Tomanek et al., 2002; Tomanek et al., 2006b; Tomanek et al., 
2001). A gradient of VEGF expression across the ventricular wall has been observed in 
embryonic hearts that positively correlates with the level of hypoxia as detected by hypoxia 
indicators and HIF-1a nuclear localization (Sugishita et al., 2004b; Wikenheiser et al., 2006) 
and the density of vascular tubes (Tomanek et al., 2001). FGFs are also found in this gradient 
pattern and ectopic FGF expression caused abnormal coronary patterning within the 
ventricular wall (Pennisi and Mikawa, 2005). FGF family members are increased in their 
expression and secreted under hypoxic conditions in other systems (Berger et al., 2003; 
Moeller et al., 2004). Many factors important in coronary vessel formation are known to be 
hypoxia inducible and/or controlled directly or indirectly by HIF-1 in other systems.  
In summary, a distinguishing feature of the sulcus regions of the heart where the coronary 
vessels first begin to develop and where the largest coronary arteries end up is a high level 
of hypoxia and nuclear-localized HIF-1a as well as a high level of expression of HIF 
downstream genes in both the myocardium and epicardium (Fig. 7).  
Abnormally high HIF-1 activity results in abnormal coronary vessel development. If 
hypoxia via HIFs are an important signal of coronary vessels development, the expectation 
would be that altering the hypoxic microenvironment would alter coronary vascular 
development. There is evidence from several studies that this is the case. 
Overactive HIF-1 transcriptional activity in the Cited2 knockout mouse results in coronary 
vascular abnormalities that can be rescued by reducing HIF-1a gene dosage. Cited2, a 
transcription factor that is regulated by HIF-1 transcriptional activity, down-regulates HIF-1 
dependent gene expression in vitro (Bhattacharya et al., 1999)(Bhattacharya et al., 1999). 
Structural studies (Dames et al., 2002; Freedman et al., 2002; Semenza, 2002) indicated that 
Cited2 could act as an efficient competitor to HIF-1a binding to CBP/P300 and thus serve as 
an inhibitor of HIF-1 transcriptional activation. Defects of the Cited2-/- mouse, supported 
this role for Cited2 in vivo. Cited-/- mice had abnormally high HIF-1 transcriptional 
activation in the heart and defects in regions that are particularly hypoxic, including the 
OFT and IVS (Yin et al., 2002). The mRNA levels of HIF-1-regulated genes, VEGF, PGK and 
Glut-1, were elevated in Cited-/- embryonic hearts. Levels of secreted VEGF were also 
higher in fibroblast cultures from Cited2-/- as compared to those from Cited+/+ embryos. 
Vessels in the myocardium of Cited2-/- embryos were larger and leakier resembling vessels 
developing with VEGF overexpression (Xu et al., 2007). Reducing the gene dosage of HIF-1a 
in Cited2-/- mice by mating with the HIF-1a knockout line, partially rescued the cardiac 
defects (Xu et al., 2007). The coronary vasculature and VEGF mRNA transcription were also 
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closer to normal. These results suggested that hypoxia in embryonic heart tissues induces 
HIF-1 activity to support normal coronary vascular development, but inappropriately high 
levels of HIF-1 activity have a detrimental effect on coronary vascular and cardiac 
development. We could not conclude the cell type requirement for HIF-1a and Cited2 using 
these global Cited2 and HIF-1 knockout mice,  
Hypoxic and hyperoxic conditions during embryogenesis alter coronary artery 
architecture. Regimens of hypoxia (15% O2) and hyperoxia compatible with long-term 
embryo survival caused coronary artery anomalies in chicken embryos (Wikenheiser et al., 
2009)(Fig. 3,4). Regions with relatively high levels of microenvironmental hypoxia within 
the heart correlated with the expression of HIF-1 nuclear localization and HIF downstream 
genes at sulcus regions where the epicardium is thickest and where the largest arteries 
develop. Experimentally increasing the level of hypoxia caused a broadening in the regions 
of HIF-1a nuclear localized expression within the myocardium and epicardium, abnormal 
expression of HIF-1 downstream genes, thickening of the epicardium, disruption of the 
patterns of the early precursors of the coronaries and coronary artery anomalies. The 
epicardial cells at these sites have a very specific expression of nuclear-localized HIF-1a and 
N1ICD that indicates that in addition to the paracrine effects of HIFs from the adjacent 
myocardium, there may be a cell autonomous role for HIF and Notch in the embryonic 
epicardium (Yang et al., 2009). 
Another consideration is the role that normal or abnormal vasculature can play in directing 
development of other tissues. Vascular development is intimately involved in the growth 
and development of the liver and pancreas from early inductive events (Bahary and Zon, 
2001; Lammert et al., 2001; Lammert et al., 2003; Matsumoto et al., 2001). Evidence also 
supports the influence of coronary precursors and vessels on myocardial development and 
function and vice versa (Manner et al., 2001). For example, Purkinje fiber differentiation in 
avian systems appears to be controlled by factors from the coronary endothelium (Gourdie 
et al., 1998). Thus, understanding the factors that regulate normal coronary vascular development is 
critical to a general understanding of embryonic and adult cardiac diseases and diseases of other 
tissues.  
7. Regulating the coronary vessels within the adult heart for cardiotherapy 
The adult heart can adapt to stress by hypertrophy and vascular growth/remodeling 
(Bernardo et al., 2010; Weeks KL and McMullen JR, 2011). Physiological or adaptive 
responses, as in the case of the exercised trained athelete’s heart, are characterized by 
balanced changes in both the cardiomyocytes and the vasculature. Negative consequences 
arise when these responses are not coordinated, as in the case of prolonged hypertension, 
and can lead to heart failure, arrhythmia, and death. The physiological and pathological 
responses overlap in some respects, especially in the early stages of adaptation. However, 
there are distinct characteristics to the physiological and pathological responses that have 
been revealed by studies in humans and rodent models (Boström P et al., 2010; Pavlik G et 
al., 2010; Weeks KL and McMullen JR, 2011). These differences include the degree of 
vascularization of the myocardium with the physiological response leading to increased 
vascularization. 
Vascular development in the adult heart. Angiogenesis within the myocardium is not 
limited to developmental stages, but may occur when the mature heart is challenged by 
enhanced loading conditions or during hypoxia or ischemia. Angiogenesis in the setting of 
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the adult heart can be regulated by hypoxia-induced responses through HIF-1a, that can 
directly regulate endothelial cell activity and increase capillary density (Pugh CW and 
Ratcliffe PJ, 2003). Another mechanism is associated with a general stress response following 
acute hemodynamic overload or hypertrophy induced by exercise or pregnancy (Hilfiker-
Kleiner D et al., 2005; Jacobs TB et al., 1984; Sano M et al., 2007; Waters RE et al., 2004). This 
response would allow the myocardium to coordinate an increase in microvessels with an 
ensuing hypertrophic response. This load-induced angiogenic response would also protect 
the heart from developing ischemia, possibly delaying decompensation. That HIF-1 was 
also activated by mechanical overload (Kim CH et al., 2002) suggests that there is some 
overlap in the mechanisms. 
7.1 Myocardial hypertrophy and angiogenesis  
Cardiac hypertrophy is associated with upregulation of VEGF in the myocardium (Izumiya 
Y et al., 2006). VEGF is required to maintain myocardial capillary density and reductions in 
the vascular bed are associated with the transition from compensatory hypertrophy to 
failure (Anversa P et al., 1986; Hudlicka O et al., 1992). In contrast, cardiac growth associated 
with development, nutritional input, or vigorous exercise is associated with maintained or 
increased capillary density (Hudlicka O et al., 1992; Shiojima I et al., 2002). Thus, the 
availability of VEGF may play a role in determining whether the phenotype of the growing 
heart is "physiological" or "pathological" (Shiojima I et al., 2005). In addition to the VEGF 
family, bFGF and angiopoietins play major roles in myocardial vascularization (Tomanek RJ 
et al., 1998; Visconti RP et al., 2002). 
It was recently demonstrated that angiogenesis can induce myocardial hypertrophy even in 
the absence of a hemodynamic stimulus (Tirziu D et al., 2007). In this study an increase in 
the size of the vascular bed resulted in increased cardiac mass and myocardial hypertrophy 
paralleled by increased cardiac performance. This points out a complex role played by the 
endothelium of the heart (and likely other organs) that involves not only participation in a 
stress response but also regulation of the organ’s size. The increase in heart size ceased once 
the vascular density returned to normal levels (Tirziu D et al., 2007).  
Several important transcription factors have been studied for their ability to regulate the 
coronary vasculature in the adult mouse. These include GATA4 and CEBPb. The coronary 
vasculature within the myocardium increases in density when GATA4 expression is up-
regulated (Heineke et al., 2007), or when CEBPb is down-regulated (Boström P et al., 2010)   
These vascular changes are also accompanied by improvement in function and survival 
when mice are subjected to a model of myocardial infarction. While effects on the coronary 
vasculature are not the only positive changes, this change is probably very important in 
providing coronary reserve during stresses. These promising preclinical findings suggest 
that targeting ways to regulate the transcription factors may be important in finding 
strategies for cardioprotection via increased vascularization.  
If it is possible to find the pathways that lead to the morphology, physiology, and gene 
expression that resemble those of a physiological rather than a pathological response, that 
knowledge may allow us to coordinate a host of beneficial responses for the heart that 
would protect it from ischemic insults.  
The adult epicardium has recently been shown to act as a paracrine source of factors that 
increases vessel density and benefits the health of cardiomyocytes (Zhou et al., 2011). 
Preclinical studies to develop potential therapies and expected challenges. To prevent or 
alleviate effects of heart disease including myocardial infarction and heart failure, it would 
www.intechopen.com
 Vasculogenesis and Angiogenesis – From Embryonic Development to Regenerative Medicine 36
be beneficial to increase the density of the vasculature and therefore perfusion of the 
myocardium. This increase would have to be controlled and the right mix of vessels would 
have to be formed in the right place at the right time. This enhancement of the coronary 
vasculature could be encouraged prior to surgery, or in early stages of coronary artery 
disease when a coronary occlusion is first noted or when early signs of pathological 
hypertrophy are identified. In cases of some anomalous coronaries it would be beneficial to 
encourage collateralization in a controlled way. An ability to promote and nudge coronary 
vessel development at the right time and place could benefit the outcome of many cardiac 
diseases. 
Gene therapy. Current pharmacologic therapy for ischemic heart disease is limited by 
several issues including patient compliance and side effects of the medications (Lavu et al., 
2011). Also a significant population of patients do not respond to the best medical therapy 
available. Gene therapy may be a promising alternative that is currently being investigated. 
Gene therapy with isoforms of growth factors such as Vascular Endothelial Growth Factor A 
(VEGFA) , Fibroblast Growth Factor (FGF) and Hepatocyte Growth Factor (HGF) induces 
angiogenesis, decreases apoptosis and leads to protection in the ischemic heart. Stem cell 
therapy combined with gene therapy promotes myogenesis in animal models of myocardial 
ischemia. Gene therapy that induces the expression of antioxidants, eNOS, SP, mitogen 
activated protein kinase and other anti-apoptotic proteins have also been shown to be 
beneficial in animal models. Clinical trials currently show mixed results and the 
interpretation of the results are controversial, but some of the therapies appear to be safe.  
Vascular endothelial growth factor (VEGF) gene therapy: VEGFA is a highly investigated 
growth factor that induces angiogenesis in the ischemic heart. Isoforms of VEGFA bind to 
specific receptors on endothelial cells and play an essential role in angiogenesis (Hao et al., 
2007). VEGFA-165 (VEGFA isoform) gene therapy using plasmids in rats (Dong et al., 2009; 
Yockman et al., 2009) or through non-viral delivery systems in rabbits (Aoki et al., 2000) 
induces significant neovascularization and improves fractional shortening after modeling 
myocardial infarction (MI). 
Concerns with angiogenic therapies exist because VEGFA is a powerful factor whose 
expression level must be tightly regulated in isoform expression, timing and location. 
Deviation from normal levels are known to cause pathology in animal models [e.g. (Autiero 
et al., 2005; Carmeliet et al., 1996; Flamme et al., 1995; Kaner et al., 2000)]. Novel gene 
constructs have been created that would allow the gene expression to be responsive to the 
cellular environments. For example, some constructs allow VEGFA levels to be increased 
specifically during cardiac ischemia. 
(Lee et al., 2003; Su et al., 2002) and the treated animals have reduced infarct size and 
increased angiogenesis (Dong et al., 2009; Yockman et al., 2009).  
Hepatocyte growth factor gene therapy: Human Hepatocyte Growth Factor (hHGF) gene 
therapy induced angiogenesis in rats and dogs after experimental myocardial infarction 
(MI) and also improved cardiac function (Ahmet et al., 2002; Ahmet et al., 2003; Cho et al., 
2008; Jayasankar et al., 2003; Jin et al., 2004; Li et al., 2003; Taniyama et al., 2002; Yang et al., 
2007; Yang et al., 2010). HGF gene therapy combined with a novel gene transfection strategy 
that looks promising  in a rat model of MI (Ahmet et al., 2003) is currently being evaluated 
in clinical trials. 
Fibroblast growth factor gene therapy: Fibroblast growth factors FGF-1 and FGF-2 are 
known to promote endothelial cell proliferation and formation of tube-like endothelial 
structures in various pre-clinical models. FGF-2 gene therapy has been shown to improve 
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arteriogenesis and left ventricular (LV) function in a model of chronic ischemia in pigs 
(Heilmann et al., 2002; Horvath et al., 2002).  
Angiogenesis through genetically modified cells: Genetically modified cells can be used to 
express the transgene of choice and lead to increased levels of the desired proteins in target 
tissues such as the heart. One obvious potential benefit of this strategy is its ability to 
activate precursor cells to differentiate into cardiac phenotypes, incorporate into the 
myocardium and prevent or alleviate harmful cardiac remodeling (Atkins et al., 1999)[29]. 
Vascular smooth muscle cells (VSMCs) modified to overexpress VEGF, when administered 
by the intra-coronary route in an intermittent repetitive LAD occlusion model increased 
collateral circulation in the ischemic heart (Hattan et al., 2004). Fibroblasts, modified to 
overexpress bFGF gene, when administered by coronary injections in a swine model of 
chronic ischemia led to improved collateral formation and myocardial contraction as 
measured by coronary angiography and electromechanical mapping (Ninomiya et al., 2003). 
Some advantages of mesenchymal stem cells (MSCs) are their ability to be transduced by 
vectors easily, ability to be delivered systemically and their capacity to home in to damaged 
tissues. MSCs also possess low immunogenicity and hence can be used allogenically 
(Ninomiya et al., 2003). 
8. Overall summary 
There are still many puzzling aspects of cardiac vessel development and anatomy that 
require further investigation. Fundamental questions regarding lymphangiogenesis in the 
heart may now be approachable with techniques and reagents currently available and 
already reveal surprising and puzzling findings. It is still unknown how coronary vessel 
anomalies develop. Discussions continue on the best way to detect them clinically and how 
to proceed once detected. Experiments on the developmental biology of coronary vessel 
development in genetically engineered mice have led to promising leads towards reducing 
or alleviating the consequences of myocardial infarction and heart disease so as to slow or 
prevent the progression to heart failure and death. By understanding the mechanisms that 
control coronary vessel localization and density, it may be possible to increase coronary 
vasculature with therapies even when exercise is not an option as a preventative measure to 
reduce or prevent myocardial ischemic damage during surgery or for individuals with a 
family history of heart disease. 
9. Abbreviations 
ALCAPA Anomalous Left Coronary Artery from Pulmonary Artery 
ASD Atrial Septal Defect
AV Atrioventricular
BMP Bone Morphogenetic Protein
CAD Coronary Artery Disease
CF Circumflex Artery
EGF Endothelial Growth Factor
EMT Epithelial Mesenchymal Transition
EPDC Epicardial Derived Cells
FGF Fibroblast Growth Factor
FOG Friend of GATA 
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HIF Hypoxia Inducible Factor 
HRE Hypoxia Responsive Elements 
LAD Left Anterior Descending Coronary Artery 
MI Myocardial Infarction 
OFT Outflow Tract 
PDA Posterior Descending Artery 
PE Proepicardium 
PEO Proepicardial Organ 
RCA Right Coronary Artery 
TGF Transforming Growth Factor 
VEGF Vascular Endothelial Growth Factor 
VSD Ventricular Septal Defect 
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